Results 181 to 190 of about 39,759 (339)

Activation and Preparedness for Survivorship Care Among Survivors of Oral and Oropharyngeal Cancers

Head &Neck, EarlyView.
ABSTRACT Objective The objectives were to characterize activation and preparedness for survivorship care and identify key sociodemographic variables, medical characteristics, care transition experiences, and psychosocial factors associated with preparedness and activation among recent oral and oropharyngeal cancer survivors.
Sharon L. Manne, Shawna V. Hudson, Janet Van Cleave, Marissa Grosso, Sara Frederick, Morgan Pesanelli, Justin Solleder, Elizabeth Handorf   +7 more
wiley   +1 more source

A Rare Case of Mastoid Process Osteoma Presenting During Puberty: A Case Report. [PDF]

Reports (MDPI)
Topalova-Shishmanova A, Pavlov G.
europepmc   +1 more source

Examining the Relationship Between Dysphagia, Eating‐Related Symptoms, and Diet Quality Among Oropharyngeal Cancer Patients During Critical Stages of Cancer Survivorship: The U‐DINE Study

Head &Neck, EarlyView.
ABSTRACT Background Diet quality is a modifiable factor impacting treatment outcomes in oropharyngeal cancer (OPC), yet the effect of dysphagia and self‐reported eating‐related symptoms remains unclear. This study examined their associations with diet quality in OPC patients.
Beatrice Manduchi, Vlad C. Sandulache, Ji Yun Tark, Shreela Sharma, Ruosha Li, Emily Roller, Andrew Bevelhimer, Katherine A. Hutcheson, Marcia C. de Oliveira Otto   +8 more
wiley   +1 more source

The persistent risk of secondary malignancies in gastric neuroendocrine tumor survivors: a population-based analysis. [PDF]

Clin Exp Med
Ding Y, Liu J, Shen L, Yan Z, Huang Y, Huang Y, Huang R, Qian Y, Lou X, Wang L.   +9 more
europepmc   +1 more source

Geographic and Socioeconomic Landscape of Veterans With Head and Neck Cancer

Head &Neck, EarlyView.
ABSTRACT Background US Veterans experience higher rates and worse outcomes for head and neck squamous cell carcinoma (HNSCC) compared to civilians. Geographic and socioeconomic barriers remain unclear. Methods This retrospective descriptive study analyzed VA data nationwide (2012–2022), identifying Veterans with HNSCC using ICD codes. Subsites included
Kristen L. Zayan, Jennifer L. McCoy, Monique Y. Boudreaux‐Kelly, Chad Brenner, Zachary Hahn, Jose P. Zevallos, Matthew E. Spector, John Hotchkiss, Jessica H. Maxwell   +8 more
wiley   +1 more source

Earlobe Pilomatrixoma in Children: Clinical Features and Surgical Management. [PDF]

Am J Case Rep
Alkhaldi A, Althwanay R, Alsalamah AS, Aldakheel AM, Awad BI, Halawani M.   +5 more
europepmc   +1 more source

Computed tomographic appearance of melanomas in the equine head: 13 cases [PDF]

A, Albanese, Barnett, Chénier, Cissell, Cotchin, Crijns, Dakin, Dixon, Dyson, Enochs, Fintl, Fukunaga, Ginaldi, Grahn, Holtås, Kalkman, Kato, Lerner, Lucas, Manso-Díaz, McFadyean, Moore, Parizel, Pellegrini, Phillips, Premkumar, Sasaki, Seltenhammer, Textor, Tietje, Tremaine, Uozumi, Valentine, WG, Wörz   +35 more
core   +1 more source

Sarcopenia Trajectories Predict Survival in Operable Head and Neck Cancer

Head &Neck, EarlyView.
ABSTRACT Background Sarcopenia is associated with increased treatment toxicity and survival in head and neck squamous cell cancer (HNSCC). This study evaluates sarcopenia trajectories and their association with overall survival (OS) and disease‐free survival (DFS) in operable HNSCC.
Marco A. Mascarella, Alex Mlynarek, Keith Richardson, Karen Kost, Anthony Zeitouni, Khalil Sultanem, Christina Tsien, George Shenouda, Nathaniel Bouganim, Khashayar Esfahani, Michael Hier, Nader Sadeghi, Marie‐Jeanne Kergoat   +12 more
wiley   +1 more source

Pulsatile Tinnitus: A Comprehensive Clinical Approach to Diagnosis and Management. [PDF]

J Clin Med
Pacheco-López S, Martínez-Barbero JP, Busquier-Hernández H, García-Valdecasas-Bernal J, Espinosa-Sánchez JM.   +4 more
europepmc   +1 more source

First‐Line Therapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective, Multicenter, Real‐World Study

Head &Neck, EarlyView.
ABSTRACT Background In Europe, pembrolizumab with or without chemotherapy is the recommended first‐line treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), with a combined positive score (CPS) ≥ 1. In France, the TPExtreme (TPEx) regimen is preferred for CPS < 1.
Alizée Simon, Cyril Abdeddaim, DucTrung Nguyen, Patrice Gallet, Didier Peiffert, Aurélien Lambert, Lionnel Geoffrois   +6 more
wiley   +1 more source